LC-ESI-MS/MS analysis of quercetin in rat plasma after oral administration of biodegradable nanoparticles

被引:16
作者
Kumar, Dinesh V. [1 ]
Verma, Priya Ranjan Prasad [1 ]
Singh, Sandeep Kumar [1 ]
Viswanathan, S. [2 ]
机构
[1] Birla Inst Technol, Dept Pharmaceut Sci & Technol, Ranchi, Jharkhand, India
[2] Micro Therapeut Res Labs Private Ltd, Madras 600097, Tamil Nadu, India
关键词
LC-MS; MS; Quercetin; Pharmacokinetic; Nanoparticles; PERFORMANCE LIQUID-CHROMATOGRAPHY; TANDEM MASS-SPECTROMETRY; ELECTROCHEMICAL DETECTION; POLYMERIC NANOPARTICLES; ANTIOXIDANT ACTIVITY; DRUG-DELIVERY; METABOLITES; PHARMACOKINETICS; DISPOSITION; THERAPY;
D O I
10.1002/bmc.3486
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
A simple, rapid and sensitive LC-MS/MS method was developed and validated for the determination of free quercetin in rat plasma, using fisetin as internal standard. The detection was performed by negative ion electrospray ionization under selected reaction monitoring. Chromatographic separation (isocratic elution) was carried out using acetonitrile-10m m ammonium formate (80:20, v/v) with 0.1% v/v formic acid. The lower limit of quantification (4.928ng/mL) provided high sensitivity for the detection of quercetin in rat plasma. The linearity range was from 5 to 2000ng/mL. Intra- and inter-day variability (RSD) of quercetin extraction from rat plasma was <4.19 and 1.37% with accuracies of 98.77 and 99.67%. The method developed was successfully applied for estimating free quercetin in rat plasma, after oral administration of quercetin-loaded biodegradable nanoparticles (QLN) and quercetin suspension. QLN (C-max, 1277.34 +/- 216.67ng/mL; AUC, 17,458.25 +/- 3152.95nghr/mL) showed a 5.38-fold increase in relative bioavailability as compared with quercetin suspension (C-max, 369.2 +/- 108.07ng/mL; AUC, 3276.92 +/- 396.67nghr/mL). Copyright (c) 2015 John Wiley & Sons, Ltd.
引用
收藏
页码:1731 / 1736
页数:6
相关论文
共 30 条
[1]  
[Anonymous], 2011, GUIDE CARE USE LAB A
[2]  
[Anonymous], 2013, Guidance for Industry: Bioanalytical method validation
[3]   Quercetin: potentials in the prevention and therapy of disease [J].
Bischoff, Stephan C. .
CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE, 2008, 11 (06) :733-740
[4]   Health effects of quercetin: From antioxidant to nutraceutical [J].
Boots, Agnes W. ;
Haenen, Guido R. M. M. ;
Bast, Aalt .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2008, 585 (2-3) :325-337
[5]   Pharmacokinetics and modeling of quercetin and metabolites [J].
Chen, X ;
Yin, OQP ;
Zuo, Z ;
Chow, MSS .
PHARMACEUTICAL RESEARCH, 2005, 22 (06) :892-901
[6]   Biomedical applications of nanotechnology - Implications for drug targeting and gene therapy [J].
Davis, SS .
TRENDS IN BIOTECHNOLOGY, 1997, 15 (06) :217-224
[7]   Quercetin-PVP K25 solid dispersions: Preparation, thermal characterization and antioxidant activity [J].
de Mello Costa, Ana Rita ;
Marquiafavel, Flavia Silva ;
Lima Leite Vaz, Mirela Mara de Oliveira ;
Rocha, Bruno Alves ;
Pires Bueno, Paula Carolina ;
Amaral, Pedro Luiz M. ;
Barud, Hernane da Silva ;
Ap Berreta-Silva, Andresa .
JOURNAL OF THERMAL ANALYSIS AND CALORIMETRY, 2011, 104 (01) :273-278
[8]   Plasma concentrations and urinary excretion of the antioxidant flavonols quercetin and kaempferol as biomarkers for dietary intake [J].
de Vries, JHM ;
Hollman, PCH ;
Meyboom, S ;
Buysman, MNCP ;
Zock, PL ;
van Staveren, WA ;
Katan, MB .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 1998, 68 (01) :60-65
[9]   Validated method for the quantitation of quercetin from human plasma using high-performance liquid chromatography with electrochemical detection [J].
Erlund, I ;
Alfthan, G ;
Siren, H ;
Ariniemi, K ;
Aro, A .
JOURNAL OF CHROMATOGRAPHY B, 1999, 727 (1-2) :179-189
[10]   Pharmacokinetics of quercetin from quercetin aglycone and rutin in healthy volunteers [J].
Erlund, I ;
Kosonen, T ;
Alfthan, G ;
Mäenpää, J ;
Perttunen, K ;
Kenraali, J ;
Parantainen, J ;
Aro, A .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2000, 56 (08) :545-553